Poster Presentations

Our Data Presented

We benefit greatly from ongoing discussions of our data with the medical and public health communities.

Our posters facilitate these discussions by highlighting key data for presentation at global conferences.

VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM

Presented at: 2020 Annual Meeting of the Society for Neuro-Oncology (SNO)
November 19, 2020
Read MoreArrow

VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at The Liver Meeting® 2020

Presented at: American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting® 2020
November 13, 2020
Read MoreArrow

VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at ID Week 2020™

Presented at: IDWeek 2020™
October 26, 2020
Read MoreArrow

ESMO-2020-Poster

VBI Vaccines Announces Biomarker Data from VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020

Presented at: The European Society for Medical Oncology (ESMO) Virtual Congress 2020
September 17, 2020
Read MoreArrow

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

Presented at: 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting
June 22, 2020
Read MoreArrow

VBI Vaccines Presents Early GBM Tumor Response and Immunologic Data from Part B of Ongoing Phase 1/2a Study of VBI-1901 at the 2019 SNO Annual Meeting

Presented at: 2019 Annual Meeting of the Society for Neuro-Oncology (SNO)
November 22, 2019
Read MoreArrow

VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver Meeting® 2019

Presented at: American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting® 2019
October 22, 2019
Read MoreArrow

VBI-poster-ASCO-2019-FINAL

VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019

Presented at: 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
June 4, 2019
Read MoreArrow

VBIV-EASL-2019-Poster_v2

VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019

Presented at: 2019 Annual Meeting of the European Association for the Study of the Liver (EASL)
April 9, 2019
Read MoreArrow

SNO-2018-Presentation

VBI Vaccines to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)

Presented at: 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)
October 24, 2018
Read MoreArrow

Keystone Symposia 2016

VBI Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

Presented at: Keystone Symposia Cancer Vaccines Conference
March 7, 2016
Read MoreArrow


Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up Now for our newsletterArrow
Go top